San Francisco Neurological Society

Registration now closed.

The Practical & Ethical
Implications of Access to
Cognition Altering Substances.
Saturday November 12, 2015 - 6:00 pm
Hyatt Regency San Francisco Airport

The presentation will examine the ethical, societal and political dimensions of access to cognition altering substances by both patients and healthy adults. The mutual rights and duties of the respective players will be considered in light of the state of the art and the progress of current debate.

The speaker: John Harris, British philosopher and director of The Institute for Science, Ethics, and Innovation at the University of Manchester, is one of the leading and most influential public figures in bioethics.

Accreditation Statement:

This San Francisco Neurological Society is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The San Francisco Neurological Society takes responsibility for the content, quality and scientific integrity of this CME activity.

Designation Statement:

The San Francisco Neurological Society designates this educational activity for an estimated 1 AMA PRA Category 1 Credit(s) TM . This credit may also be applied to the CMA Certification in Continuing Medical Education.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s) TM issued by organizations accredited by the ACCME.

Who Should Attend:

Neurologists, neurosurgeons, neuroradiologists, neuropsychologists, residents, nurses, and other physicians interested in research and clinical advances in the neurosciences.

Hyatt Regency San Francisco Airport

450 Powell Street
1333 Bayshore Hwy, Burlingame, CA 94010